External
2025.12.18
Canaph Therapeutics and Mezoo Pass KOSDAQ Listing Preliminary Review
(Seoul = Yonhap News) Reporter Eun-ji Ko — On the 18th, the Korea Exchange announced that it has approved the general listings of Canaph Therapeutics and Mezoo following the preliminary review for KOSDAQ market listing.
https://www.yna.co.kr/view/AKR20251218156200008
